Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of BTX 1503 in Patients With Moderate to Severe Acne Vulgaris

NCT03573518 is registered in ClinicalTrials.gov with Botanix Pharmaceuticals as lead sponsor.

NCT NCT03573518
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03573518 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of BTX 1503 in Patients With Moderate to Severe Acne Vulgaris
Lead sponsor
Botanix Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
June 26, 2018
Completion date
September 5, 2019
Enrollment
368 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris